SCHEMBL2290699

SCHEMBL2290699

COc1cc(/C=C/C(=O)O)c(CCC(C)C)c(OC)c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.51
ALDH1A1 P00352 8/20 0.51
HPGD P15428 5/20 0.51
HSD17B10 Q99714 2/20 0.51
HTR1A P08908 1/20 0.51
HTR2C P28335 1/20 0.51
HTT P42858 3/20 0.50
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA4 P22748 2/20 0.48
CA6 P23280 2/20 0.48
CA5A P35218 2/20 0.48
CA7 P43166 2/20 0.48
CA9 Q16790 2/20 0.48
CA14 Q9ULX7 2/20 0.48
CA5B Q9Y2D0 2/20 0.48
ALOX5 P09917 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
PKM P14618 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4017039 0.92 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL646614 0.84 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL646616 0.84 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL9119701 0.83 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL9119684 0.83 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL647484 0.81 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL647486 0.81 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL10610356 0.81 ALOX5 (0.51) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL10606235 0.81 ALOX5 (0.51) KDM4EALDH1A1HPGDHSD17B10HTR1A
SCHEMBL6675232 0.80 KDM4E (0.39) KDM4EALDH1A1HPGDHSD17B10HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110200666-A1 UV PROTECTION AGENT FOR THE SKIN OR HAIR HAVING A UV FILTER SUBSTANCE ENCAPSULATED IN A VESICULAR CARRIER SYSTEMü ROVI COSMETICS INTERNATIONAL GMBH (DE) 2011-08-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200666-A1 UV PROTECTION AGENT FOR THE SKIN OR HAIR HAVING A UV FILTER SUBSTANCE ENCAPSULATED IN A VESICULAR CARRIER SYSTEMü HNRNPU, CD44, CUTA KDM4E 3025/4885ALDH1A1 1789/4885HPGD 3134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.